Literature DB >> 6787451

Biologically stable analogues of TRH with increased neuropharmacological potency.

D Brewster, P W Dettmar, G Metcalf.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6787451     DOI: 10.1016/0028-3908(81)90184-2

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


× No keyword cloud information.
  9 in total

Review 1.  Development of neuropeptide drugs that cross the blood-brain barrier.

Authors:  Richard D Egleton; Thomas P Davis
Journal:  NeuroRx       Date:  2005-01

2.  Effects of a new TRH analogue, YM-14673 on a passive avoidance test as a possible criterion of improvement in cognitive disturbance in rodents.

Authors:  M Yamamoto; M Shimizu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-09       Impact factor: 3.000

3.  Controlled acute trial of a thyrotrophin releasing hormone analogue (RX77368) in motor neuron disease.

Authors:  R J Guiloff; D J Eckland; C Demaine; R C Hoare; K D MacRae; S L Lightman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-10       Impact factor: 10.154

4.  Electrophysiological observations in patients with motor neuron disease receiving a thyrotropin releasing hormone analogue (RX77368).

Authors:  R J Guiloff; E Stålberg; D J Eckland; S L Lightman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-12       Impact factor: 10.154

5.  Effects of a new TRH analogue, YM-14673 on the central nervous system.

Authors:  M Yamamoto; M Shimizu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-11       Impact factor: 3.000

6.  The effects of TRH analogues on cerebral ischaemia produced by middle cerebral artery occlusion in the rat.

Authors:  J Shrewsbury-Gee; R H Lye; A Latham; P Slater
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

7.  Antagonizing effects of YM-14673, a new TRH derivative, on behavioral and electroencephalographic changes in reserpinized animals.

Authors:  M Yamamoto; M Shimizu; A Iwai
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

8.  Validity of urinary monoamine assay sales under the "spot baseline urinary neurotransmitter testing marketing model".

Authors:  Marty Hinz; Alvin Stein; Thomas Uncini
Journal:  Int J Nephrol Renovasc Dis       Date:  2011-07-20

9.  Discovery of the Orally Effective Thyrotropin-Releasing Hormone Mimetic: 1-{N-[(4S,5S)-(5-Methyl-2-oxooxazolidine-4-yl)carbonyl]-3-(thiazol-4-yl)-l-alanyl}-(2R)-2-methylpyrrolidine Trihydrate (Rovatirelin Hydrate).

Authors:  Naotake Kobayashi; Norihito Sato; Yuko Fujimura; Tsuyoshi Kihara; Katsuji Sugita; Kouji Takahashi; Katsumi Koike; Tamio Sugawara; Yukio Tada; Hiroshi Nakai; Takayoshi Yoshikawa
Journal:  ACS Omega       Date:  2018-10-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.